The effects on ovarian activity of a monophasic oral contraceptive with 100 μg levonorgestrel and 20 μg ethinyl estradiol

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 5 II, 1999, Pages

  Coney, P ^a   Delconte, A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethinyl estradiol; Levonorgestrel; Oral contraceptive; Ovarian activity

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; NORMAL HUMAN; ORAL CONTRACEPTION; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

EID: 0032724698     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(99)70364-9     Document Type: Article

References (19)

1. GI Swyer V Little Clinical assessment of relative potency of progestagens J Reprod Fertil 5 suppl 1968 63 68
2. J Spona J Huber Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate Gynecol Obstet Invest 23 1987 184 193
3. HJ Hoogland SO Skouby Ultrasound evaluation of ovarian activity under oral contraceptives Contraception 47 1993 583 590
4. MM Seibel RE Blackwell Ovulation induction 1994 Raven Press New York 174
5. PG Stubblefield Health benefits beyond contraception Int J Fertil 39 suppl 3 1994 132 138
6. J Drife Benefits and risks of oral contraceptives Adv Contracept 6 suppl 1990 15 25
7. Anonymous Combined oral contraceptives: a statement by the Committee on Safety of Drugs BMJ 2 1970 231 232
8. TN Jeffcoat RCOG statement on oral contraceptives BMJ 1 1970 293
9. R Apelo I Veloso Clinical experience with ethinylestradiol and d-norgestrel as an oral contraceptive Fertil Steril 26 1975 283 288
10. IV Arnt A Ferrari JN Sartoretto TB Woutersz Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel–ethinyl estradiol ratios Fertil Steril 28 1997 549 553
11. A Teichmann H Martens C Bordasch G Petersen G Lorkowski The effects of a new low-dose combined oral contraceptive containing levonorgestrel on ovarian activity Eur J Contracept Reprod Health Care 1 1996 245 256
12. J Spona W Feichtinger C Kindermann C Wunsch K Brill Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinyl estradiol Contraception 54 1996 299 304
13. PG Bye Analysis of a multicenter trial of a new low-dose oral contraceptive in Great Britain Obstet General Scand Suppl 54 1976 61 66
14. JN Sartoretto JC Ortega-Recio Clinical evaluation of a low dosage estrogen-progesterone association (100 μg of d-norgestrel and 20 μg of ethinyl estradiol) Rev Bras Clin Terap 3 1974 399 404
15. DF Archer R Maheux A DelConte FB O’Brien A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms North American Levonorgestrel Study Group (NALSG) Contraception 55 1997 139 144
16. C Fitzgerald W Feichtinger J Spona U Muller C Williams A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation Adv Contracept 10 1994 5 18
17. J Spona M Elstein W Feichtinger H Sullivan F Lüdicke U Müller Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77
18. AT Teichmann K Brill A comparison of ovarian suppression and cycle control in women receiving monophasic oral contraceptives containing either 30 μg ethinylestradiol/75 μg gestodene or 20 μg ethinylestradiol/150 μg desogestrel Symposium of Practical Issues in Oral Contraception; Dublin June 1994
19. DR Mishell Noncontraceptive benefits of oral contraceptives J Reprod Med 38 suppl 12 1993 1021 1029